ENSG00000167548 Expression In 33 Tumors

Ensembl ID Gene symbol Log2 Foldchange Pvaue Cancer
ENSG00000167548 1.01 1.56e-17 KICH
Ensembl ID Gene symbol Cancer types Pubmed ID
ENSG00000167548 tumor 21264250
ENSG00000167548 cancers 24240169
ENSG00000167548 bladder cancer 24777035
ENSG00000167548 tumors 25123191
ENSG00000167548 breast cancer 25537518
ENSG00000167548 DLBCL 25723320
ENSG00000167548 DLBCL 25762637
ENSG00000167548 tumors 25794446
ENSG00000167548 tumors 26032282
ENSG00000167548 cancer 26092435
ENSG00000167548 DLBCL 26245647
ENSG00000167548 cancer 26341229
ENSG00000167548 tumor 26366710
ENSG00000167548 tumor 26366712
ENSG00000167548 phyllodes tumor 26437033
ENSG00000167548 DLBCL 26473533
ENSG00000167548 cancer 26657142
ENSG00000167548 embryonal tumors 26841698
ENSG00000167548 tumor 26949423
ENSG00000167548 tumors 27238212
ENSG00000167548 cancers 27707786
ENSG00000167548 tumor 27729836
ENSG00000167548 tumor 27749841
ENSG00000167548 tumors 27750214
ENSG00000167548 tumor 27842164
ENSG00000167548 tumours 27873319
ENSG00000167548 metastatic tumors 27906449
ENSG00000167548 endometrial cancer 27997699
ENSG00000167548 Small Cell Lung Cancer 28007623
ENSG00000167548 tumor 28013028
ENSG00000167548 tumor 28055972
ENSG00000167548 cancers 28249646
ENSG00000167548 tumor 28327945
ENSG00000167548 breast cancer 28336670
ENSG00000167548 breast cancer 28486103
ENSG00000167548 tumors 28611940
ENSG00000167548 tumor 28669924
ENSG00000167548 gastric cancer 28744403
ENSG00000167548 tumor 28801451
ENSG00000167548 DLBCL 28804123
ENSG00000167548 tumor 28805986
ENSG00000167548 tumors 28824725
ENSG00000167548 tumor 29178021
ENSG00000167548 cancer 29194093
ENSG00000167548 tumors 29269867
ENSG00000167548 tumor 29305415
ENSG00000167548 bladder cancer 29367767
ENSG00000167548 cancers 29440247
ENSG00000167548 cancers 29483845
ENSG00000167548 tumors 29484121
ENSG00000167548 Cancer 29489735
ENSG00000167548 tumors 29490986
ENSG00000167548 tumor 29568095
ENSG00000167548 tumors 29573965
ENSG00000167548 cervical cancer 29623014
ENSG00000167548 Non-Small-Cell Lung Cancer 29627316
ENSG00000167548 breast cancer 29748621
ENSG00000167548 cancer 29807113
ENSG00000167548 colon cancer 29925347
ENSG00000167548 tumor 29950560
ENSG00000167548 tumor 30134235
ENSG00000167548 Leydig cell tumor 30134342
ENSG00000167548 tumor 30176882
ENSG00000167548 gastric cancer 30177394
ENSG00000167548 tumours 30337373
ENSG00000167548 tumor 30400878
ENSG00000167548 cancers 30459467
ENSG00000167548 tumor 30508944
ENSG00000167548 tumours 30511242
ENSG00000167548 tumor 30569626
ENSG00000167548 prostate cancers 30616239
ENSG00000167548 tumors 30665945
ENSG00000167548 breast cancer 30679344
ENSG00000167548 cancers 30809292
ENSG00000167548 breast cancer 30943409
ENSG00000167548 tumor 30970447
ENSG00000167548 bladder cancer 30984543
ENSG00000167548 breast tumors 30990809
ENSG00000167548 tumors 31021853
ENSG00000167548 tumor 31028364
ENSG00000167548 tumor 31100540
ENSG00000167548 head and neck cancer 31123786
ENSG00000167548 cancer 31128216
ENSG00000167548 Cancer 31134918
ENSG00000167548 tumor 31199602
ENSG00000167548 tumor 31221981
ENSG00000167548 prostate cancer 31232159
ENSG00000167548 pancreatic cancer 31238554
ENSG00000167548 tumors 31366128
ENSG00000167548 DLBCL 31403034
ENSG00000167548 cancer 31427592
ENSG00000167548 tumor 31435462
ENSG00000167548 cancers 31465303
ENSG00000167548 bladder cancer 31547991
ENSG00000167548 tumor 31559120
ENSG00000167548 tumor 31719634
ENSG00000167548 tumor 31774495
ENSG00000167548 tumors 31807922
ENSG00000167548 cancer 31848314
ENSG00000167548 tumors 31913156
Ensembl ID Gene symbol Disease/phenotype Mutation type Mutated / Total samples Literature
ENSG00000167548 small cell lung carcinoma stop_gained 11.79% (52/441) 4 entries
ENSG00000167548 cecum adenocarcinoma stop_gained 18.52% (50/270) 1 entry
ENSG00000167548 esophageal squamous cell carcinoma missense_variant 19.49% (138/708) 8 entries
ENSG00000167548 colorectal adenocarcinoma frameshift_variant 10.81% (141/1304) 4 entries
ENSG00000167548 neoplasm of mature B-cells missense_variant 63.92% (62/97) 4 entries
ENSG00000167548 Mantle cell lymphoma stop_gained 20.39% (21/103) 3 entries
ENSG00000167548 bladder transitional cell carcinoma missense_variant 21.17% (116/548) 4 entries
ENSG00000167548 colorectal adenocarcinoma missense_variant 10.81% (141/1304) 6 entries
ENSG00000167548 Mantle cell lymphoma missense_variant 20.39% (21/103) 3 entries
ENSG00000167548 diffuse large B-cell lymphoma stop_gained 27.71% (143/516) 7 entries
ENSG00000167548 esophageal squamous cell carcinoma stop_gained 19.49% (138/708) 8 entries
ENSG00000167548 small cell lung carcinoma missense_variant 11.79% (52/441) 4 entries
ENSG00000167548 Endometrial Endometrioid Adenocarcinoma frameshift_variant 10.31% (67/650) 2 entries
ENSG00000167548 colon adenocarcinoma frameshift_variant 13.38% (173/1293) 7 entries
ENSG00000167548 bladder carcinoma missense_variant 13.37% (75/561) 2 entries
ENSG00000167548 esophageal squamous cell carcinoma frameshift_variant 19.49% (138/708) 7 entries
ENSG00000167548 cecum adenocarcinoma sequence_alteration 18.52% (50/270) 2 entries
ENSG00000167548 small cell lung carcinoma frameshift_variant 11.79% (52/441) 2 entries
ENSG00000167548 neoplasm of mature B-cells frameshift_variant 63.92% (62/97) 4 entries
ENSG00000167548 colon adenocarcinoma conservative_inframe_deletion 13.38% (173/1293) 4 entries
ENSG00000167548 colon adenocarcinoma amino_acid_insertion 13.38% (173/1293) 1 entry
ENSG00000167548 colon adenocarcinoma sequence_alteration 13.38% (173/1293) 2 entries
ENSG00000167548 bladder transitional cell carcinoma conservative_inframe_deletion 21.17% (116/548) 1 entry
ENSG00000167548 esophageal squamous cell carcinoma sequence_alteration 19.49% (138/708) 3 entries
ENSG00000167548 diffuse large B-cell lymphoma sequence_alteration 27.71% (143/516) 4 entries
ENSG00000167548 melanoma missense_variant 20.0% (29/145) 3 entries
ENSG00000167548 melanoma conservative_inframe_deletion 20.0% (29/145) 1 entry
ENSG00000167548 diffuse large B-cell lymphoma frameshift_variant 27.71% (143/516) 7 entries
ENSG00000167548 hemangioblastoma sequence_alteration 50.0% (15/30) 1 entry
ENSG00000167548 diffuse large B-cell lymphoma missense_variant 27.71% (143/516) 8 entries
ENSG00000167548 Mantle cell lymphoma frameshift_variant 20.39% (21/103) 3 entries
ENSG00000167548 bladder transitional cell carcinoma stop_gained 21.17% (116/548) 4 entries
ENSG00000167548 basal cell carcinoma sequence_alteration 35.29% (24/68) 1 entry
ENSG00000167548 colorectal adenocarcinoma stop_gained 10.81% (141/1304) 2 entries
ENSG00000167548 small cell lung carcinoma sequence_alteration 11.79% (52/441) 2 entries
ENSG00000167548 cecum adenocarcinoma missense_variant 18.52% (50/270) 3 entries
ENSG00000167548 Endometrial Endometrioid Adenocarcinoma missense_variant 10.31% (67/650) 3 entries
ENSG00000167548 colon adenocarcinoma missense_variant 13.38% (173/1293) 8 entries
ENSG00000167548 neoplasm of mature B-cells stop_gained 63.92% (62/97) 5 entries
ENSG00000167548 colon adenocarcinoma stop_gained 13.38% (173/1293) 2 entries
ENSG00000167548 colorectal adenocarcinoma sequence_alteration 10.81% (141/1304) 1 entry
ENSG00000167548 cecum adenocarcinoma frameshift_variant 18.52% (50/270) 4 entries
ENSG00000167548 urothelial carcinoma stop_gained 36.05% (31/86) 1 entry
ENSG00000167548 urothelial carcinoma frameshift_variant 36.05% (31/86) 1 entry
ENSG00000167548 bladder carcinoma stop_gained 13.37% (75/561) 2 entries
ENSG00000167548 urothelial carcinoma sequence_alteration 36.05% (31/86) 1 entry
ENSG00000167548 bladder transitional cell carcinoma frameshift_variant 21.17% (116/548) 6 entries
ENSG00000167548 hemangioblastoma missense_variant 50.0% (15/30) 1 entry
ENSG00000167548 basal cell carcinoma missense_variant 35.29% (24/68) 2 entries
ENSG00000167548 bladder transitional cell carcinoma sequence_alteration 21.17% (116/548) 3 entries
ENSG00000167548 bladder carcinoma frameshift_variant 13.37% (75/561) 1 entry
ENSG00000167548 lymphoid neoplasm missense_variant 32.99% (65/197) 1 entry
ENSG00000167548 urothelial carcinoma missense_variant 36.05% (31/86) 1 entry
ENSG00000167548 basal cell carcinoma stop_gained 35.29% (24/68) 2 entries
ENSG00000167548 cecum adenocarcinoma conservative_inframe_deletion 18.52% (50/270) 1 entry
ENSG00000167548 neoplasm of mature B-cells sequence_alteration 63.92% (62/97) 3 entries
ENSG00000167548 esophageal squamous cell carcinoma conservative_inframe_deletion 19.49% (138/708) 2 entries
ENSG00000167548 pancreatic neuroendocrine tumor missense_variant 1.695% (4/236) 1 entry
ENSG00000167548 Mantle cell lymphoma translational_product_function_variant 20.39% (21/103) 1 entry
ENSG00000167548 bile duct adenocarcinoma conservative_inframe_deletion 3.987% (25/627) 1 entry
ENSG00000167548 angiosarcoma stop_gained 7.018% (4/57) 2 entries
ENSG00000167548 Anal Squamous Cell Carcinoma stop_gained 14.46% (12/83) 2 entries
ENSG00000167548 acute lymphoblastic leukemia missense_variant 5.607% (18/321) 1 entry
ENSG00000167548 lung adenocarcinoma conservative_inframe_deletion 5.621% (147/2615) 2 entries
ENSG00000167548 T-cell acute lymphoblastic leukemia frameshift_variant 2.068% (14/677) 1 entry
ENSG00000167548 central nervous system primitive neuroectodermal neoplasm missense_variant 3.934% (19/483) 3 entries
ENSG00000167548 hemangioblastoma conservative_inframe_deletion 50.0% (15/30) 1 entry
ENSG00000167548 esophageal adenocarcinoma frameshift_variant 3.285% (18/548) 1 entry
ENSG00000167548 nasopharyngeal squamous cell carcinoma stop_gained 8.696% (16/184) 2 entries
ENSG00000167548 anaplastic astrocytoma stop_gained 3.053% (4/131) 1 entry
ENSG00000167548 T-cell acute lymphoblastic leukemia stop_gained 2.068% (14/677) 3 entries
ENSG00000167548 squamous cell lung carcinoma stop_gained 8.796% (84/955) 1 entry
ENSG00000167548 B-cell acute lymphoblastic leukemia frameshift_variant 4.487% (7/156) 2 entries
ENSG00000167548 cervical carcinoma missense_variant 8.696% (2/23) 2 entries
ENSG00000167548 skin melanoma missense_variant 8.755% (102/1165) 6 entries
ENSG00000167548 Mixed Lobular and Ductal Breast Carcinoma missense_variant 6.667% (5/75) 1 entry
ENSG00000167548 papillary thyroid carcinoma missense_variant 1.174% (6/511) 1 entry
ENSG00000167548 female breast carcinoma missense_variant 4.11% (12/292) 2 entries
ENSG00000167548 prostate carcinoma stop_gained 5.869% (25/426) 2 entries
ENSG00000167548 breast carcinoma stop_gained 2.75% (47/1709) 1 entry
ENSG00000167548 Thyroid Gland Undifferentiated (Anaplastic) Carcinoma stop_gained 3.788% (10/264) 2 entries
ENSG00000167548 rectal adenocarcinoma missense_variant 4.762% (26/546) 3 entries
ENSG00000167548 B-cell neoplasm stop_gained 11.11% (2/18) 1 entry
ENSG00000167548 major salivary gland adenoid cystic carcinoma stop_gained 8.0% (2/25) 1 entry
ENSG00000167548 lung adenocarcinoma sequence_alteration 5.621% (147/2615) 2 entries
ENSG00000167548 gastric adenocarcinoma frameshift_variant 7.592% (58/764) 4 entries
ENSG00000167548 head and neck squamous cell carcinoma frameshift_variant 4.147% (27/651) 1 entry
ENSG00000167548 adenosquamous lung carcinoma missense_variant 13.64% (3/22) 2 entries
ENSG00000167548 diffuse gastric adenocarcinoma stop_gained 3.571% (4/112) 2 entries
ENSG00000167548 pharyngeal squamous cell carcinoma stop_gained 11.11% (9/81) 2 entries
ENSG00000167548 breast phyllodes tumor stop_gained 11.11% (15/135) 3 entries
ENSG00000167548 brain glioblastoma stop_gained 1.731% (21/1213) 1 entry
ENSG00000167548 breast phyllodes tumor frameshift_variant 11.11% (15/135) 2 entries
ENSG00000167548 Anal Squamous Cell Carcinoma missense_variant 14.46% (12/83) 1 entry
ENSG00000167548 bladder transitional cell carcinoma amino_acid_insertion 21.17% (116/548) 1 entry
ENSG00000167548 myelodysplastic syndrome frameshift_variant 4.179% (29/694) 1 entry
ENSG00000167548 Pancreatic Acinar Cell Carcinoma stop_gained 8.824% (3/34) 1 entry
ENSG00000167548 acute lymphoblastic leukemia stop_gained 5.607% (18/321) 1 entry
ENSG00000167548 melanoma frameshift_variant 20.0% (29/145) 1 entry
ENSG00000167548 prostate carcinoma missense_variant 5.869% (25/426) 3 entries
ENSG00000167548 oral squamous cell carcinoma frameshift_variant 9.924% (26/262) 4 entries
ENSG00000167548 nasopharyngeal squamous cell carcinoma frameshift_variant 8.696% (16/184) 2 entries
ENSG00000167548 marginal zone B-cell lymphoma frameshift_variant 12.9% (4/31) 2 entries
ENSG00000167548 acute lymphoblastic leukemia frameshift_variant 5.607% (18/321) 2 entries
ENSG00000167548 non-small cell lung carcinoma missense_variant 5.155% (5/97) 2 entries
ENSG00000167548 gastric adenocarcinoma missense_variant 7.592% (58/764) 4 entries
ENSG00000167548 marginal zone B-cell lymphoma stop_gained 12.9% (4/31) 1 entry
ENSG00000167548 anaplastic oligodendroglioma sequence_alteration 9.302% (8/86) 1 entry
ENSG00000167548 prostate carcinoma frameshift_variant 5.869% (25/426) 2 entries
ENSG00000167548 chromophobe renal cell carcinoma missense_variant 2.454% (4/163) 2 entries
ENSG00000167548 gastric intestinal type adenocarcinoma missense_variant 12.04% (13/108) 2 entries
ENSG00000167548 testicular seminoma missense_variant 5.128% (4/78) 1 entry
ENSG00000167548 Thyroid Gland Undifferentiated (Anaplastic) Carcinoma missense_variant 3.788% (10/264) 2 entries
ENSG00000167548 acute myeloid leukemia missense_variant 1.063% (28/2633) 4 entries
ENSG00000167548 rectal adenocarcinoma frameshift_variant 4.762% (26/546) 2 entries
ENSG00000167548 breast phyllodes tumor missense_variant 11.11% (15/135) 2 entries
ENSG00000167548 metaplastic breast carcinoma frameshift_variant 9.756% (8/82) 2 entries
ENSG00000167548 Pleural Epithelioid Mesothelioma missense_variant 2.439% (5/205) 3 entries
ENSG00000167548 chronic lymphocytic leukemia stop_gained 0.9858% (9/913) 2 entries
ENSG00000167548 lung carcinoid tumor stop_gained 7.407% (2/27) 2 entries
ENSG00000167548 Breast Carcinoma by Gene Expression Profile conservative_inframe_deletion 7.955% (105/1320) 1 entry
ENSG00000167548 Fibroadenoma frameshift_variant 6.757% (5/74) 2 entries
ENSG00000167548 endometrium adenocarcinoma missense_variant 6.667% (2/30) 1 entry
ENSG00000167548 T-cell acute lymphoblastic leukemia missense_variant 2.068% (14/677) 3 entries
ENSG00000167548 breast ductal adenocarcinoma stop_gained 3.14% (54/1720) 6 entries
ENSG00000167548 brain glioblastoma missense_variant 1.731% (21/1213) 1 entry
ENSG00000167548 adrenal cortex carcinoma missense_variant 1.587% (3/189) 1 entry
ENSG00000167548 Ampulla of Vater Carcinoma missense_variant 4.706% (4/85) 1 entry
ENSG00000167548 myelodysplastic syndrome stop_gained 4.179% (29/694) 1 entry
ENSG00000167548 nasopharyngeal squamous cell carcinoma missense_variant 8.696% (16/184) 3 entries
ENSG00000167548 desmoplastic medulloblastoma frameshift_variant 14.71% (5/34) 2 entries
ENSG00000167548 prostate adenocarcinoma frameshift_variant 3.935% (85/2160) 5 entries
ENSG00000167548 Merkel cell skin cancer missense_variant 15.79% (15/95) 3 entries
ENSG00000167548 prostate adenocarcinoma stop_gained 3.935% (85/2160) 2 entries
ENSG00000167548 bile duct adenocarcinoma missense_variant 3.987% (25/627) 2 entries
ENSG00000167548 Non-Functioning Adrenal Cortex Adenoma missense_variant 9.091% (2/22) 1 entry
ENSG00000167548 neoplasm missense_variant 6.897% (2/29) 1 entry
ENSG00000167548 anaplastic astrocytoma missense_variant 3.053% (4/131) 1 entry
ENSG00000167548 Uterine Carcinosarcoma missense_variant 1.351% (2/148) 1 entry
ENSG00000167548 esophageal adenocarcinoma sequence_alteration 3.285% (18/548) 1 entry
ENSG00000167548 embryonal rhabdomyosarcoma missense_variant 3.488% (3/86) 2 entries
ENSG00000167548 lung adenocarcinoma frameshift_variant 5.621% (147/2615) 2 entries
ENSG00000167548 breast ductal adenocarcinoma frameshift_variant 3.14% (54/1720) 2 entries
ENSG00000167548 oral squamous cell carcinoma missense_variant 9.924% (26/262) 6 entries
ENSG00000167548 Breast Carcinoma by Gene Expression Profile missense_variant 7.955% (105/1320) 5 entries
ENSG00000167548 Invasive Breast Carcinoma stop_gained 6.522% (3/46) 1 entry
ENSG00000167548 Cutaneous Follicular Lymphoma frameshift_variant 100.0% (2/2) 2 entries
ENSG00000167548 laryngeal squamous cell carcinoma stop_gained 17.07% (7/41) 2 entries
ENSG00000167548 oral squamous cell carcinoma sequence_alteration 9.924% (26/262) 2 entries
ENSG00000167548 prostate carcinoma sequence_alteration 5.869% (25/426) 1 entry
ENSG00000167548 oral squamous cell carcinoma stop_gained 9.924% (26/262) 5 entries
ENSG00000167548 urothelial carcinoma conservative_inframe_deletion 36.05% (31/86) 1 entry
ENSG00000167548 prostate adenocarcinoma conservative_inframe_deletion 3.935% (85/2160) 2 entries
ENSG00000167548 lobular breast carcinoma frameshift_variant 3.261% (9/276) 1 entry
ENSG00000167548 Splenic Diffuse Large B-Cell Lymphoma frameshift_variant 75.0% (3/4) 2 entries
ENSG00000167548 gastric intestinal type adenocarcinoma frameshift_variant 12.04% (13/108) 2 entries
ENSG00000167548 metaplastic breast carcinoma stop_gained 9.756% (8/82) 2 entries
ENSG00000167548 small cell lung carcinoma conservative_inframe_deletion 11.79% (52/441) 1 entry
ENSG00000167548 breast ductal adenocarcinoma missense_variant 3.14% (54/1720) 4 entries
ENSG00000167548 undifferentiated pleomorphic sarcoma missense_variant 4.839% (3/62) 1 entry
ENSG00000167548 squamous cell lung carcinoma sequence_alteration 8.796% (84/955) 1 entry
ENSG00000167548 acute myeloid leukemia frameshift_variant 1.063% (28/2633) 1 entry
ENSG00000167548 hepatocellular carcinoma missense_variant 2.632% (26/988) 2 entries
ENSG00000167548 prostate adenocarcinoma sequence_alteration 3.935% (85/2160) 1 entry
ENSG00000167548 carcinosarcoma missense_variant 100.0% (3/3) 1 entry
ENSG00000167548 central nervous system primitive neuroectodermal neoplasm stop_gained 3.934% (19/483) 2 entries
ENSG00000167548 central nervous system primitive neuroectodermal neoplasm frameshift_variant 3.934% (19/483) 4 entries
ENSG00000167548 ovarian serous adenocarcinoma missense_variant 1.779% (15/843) 3 entries
ENSG00000167548 head and neck squamous cell carcinoma sequence_alteration 4.147% (27/651) 1 entry
ENSG00000167548 papillary thyroid carcinoma frameshift_variant 1.174% (6/511) 1 entry
ENSG00000167548 skin melanoma stop_gained 8.755% (102/1165) 4 entries
ENSG00000167548 Gastrointestinal stromal tumor missense_variant 3.289% (5/152) 1 entry
ENSG00000167548 Merkel cell skin cancer stop_gained 15.79% (15/95) 2 entries
ENSG00000167548 myelodysplastic syndrome missense_variant 4.179% (29/694) 1 entry
ENSG00000167548 bile duct adenocarcinoma frameshift_variant 3.987% (25/627) 1 entry
ENSG00000167548 pancreatic ductal adenocarcinoma stop_gained 3.432% (59/1719) 2 entries
ENSG00000167548 lung adenocarcinoma stop_gained 5.621% (147/2615) 5 entries
ENSG00000167548 bile duct adenocarcinoma stop_gained 3.987% (25/627) 2 entries
ENSG00000167548 Gallbladder Adenocarcinoma sequence_alteration 4.651% (8/172) 1 entry
ENSG00000167548 squamous cell lung carcinoma frameshift_variant 8.796% (84/955) 2 entries
ENSG00000167548 mucosal melanoma missense_variant 4.286% (3/70) 1 entry
ENSG00000167548 breast ductal adenocarcinoma sequence_alteration 3.14% (54/1720) 1 entry
ENSG00000167548 gastric adenocarcinoma stop_gained 7.592% (58/764) 2 entries
ENSG00000167548 Mantle cell lymphoma conservative_inframe_deletion 20.39% (21/103) 1 entry
ENSG00000167548 ulcerative colitis missense_variant 44.44% (4/9) 1 entry
ENSG00000167548 Breast Carcinoma by Gene Expression Profile frameshift_variant 7.955% (105/1320) 2 entries
ENSG00000167548 clear cell renal carcinoma missense_variant 1.743% (32/1836) 7 entries
ENSG00000167548 myelodysplastic syndrome amino_acid_insertion 4.179% (29/694) 1 entry
ENSG00000167548 small intestinal adenocarcinoma missense_variant 14.29% (3/21) 1 entry
ENSG00000167548 gastric adenocarcinoma sequence_alteration 7.592% (58/764) 1 entry
ENSG00000167548 Breast Diffuse Large B-Cell Lymphoma missense_variant 10.53% (2/19) 1 entry
ENSG00000167548 breast carcinoma missense_variant 2.75% (47/1709) 5 entries
ENSG00000167548 cervical squamous cell carcinoma stop_gained 5.538% (18/325) 1 entry
ENSG00000167548 HER2 Positive Breast Carcinoma missense_variant 7.018% (8/114) 1 entry
ENSG00000167548 pancreatic ductal adenocarcinoma missense_variant 3.432% (59/1719) 3 entries
ENSG00000167548 gastric intestinal type adenocarcinoma stop_gained 12.04% (13/108) 2 entries
ENSG00000167548 rectal adenocarcinoma sequence_alteration 4.762% (26/546) 1 entry
ENSG00000167548 thyroid carcinoma missense_variant 2.7% (25/926) 1 entry
ENSG00000167548 prostate adenocarcinoma missense_variant 3.935% (85/2160) 4 entries
ENSG00000167548 neuroendocrine carcinoma stop_gained 42.86% (3/7) 1 entry
ENSG00000167548 chronic lymphocytic leukemia missense_variant 0.9858% (9/913) 1 entry
ENSG00000167548 lobular breast carcinoma missense_variant 3.261% (9/276) 1 entry
ENSG00000167548 acute myeloid leukemia stop_gained 1.063% (28/2633) 2 entries
ENSG00000167548 diffuse large B-cell lymphoma conservative_inframe_deletion 27.71% (143/516) 1 entry
ENSG00000167548 head and neck squamous cell carcinoma stop_gained 4.147% (27/651) 1 entry
ENSG00000167548 papillary renal cell carcinoma missense_variant 2.785% (11/395) 3 entries
ENSG00000167548 head and neck squamous cell carcinoma missense_variant 4.147% (27/651) 2 entries
ENSG00000167548 anaplastic oligodendroglioma missense_variant 9.302% (8/86) 1 entry
ENSG00000167548 clear cell renal carcinoma stop_gained 1.743% (32/1836) 1 entry
ENSG00000167548 desmoplastic medulloblastoma sequence_alteration 14.71% (5/34) 1 entry
ENSG00000167548 chronic myelomonocytic leukemia missense_variant 7.143% (11/154) 2 entries
ENSG00000167548 breast carcinoma frameshift_variant 2.75% (47/1709) 2 entries
ENSG00000167548 Breast Carcinoma by Gene Expression Profile amino_acid_insertion 7.955% (105/1320) 1 entry
ENSG00000167548 lung adenocarcinoma missense_variant 5.621% (147/2615) 9 entries
ENSG00000167548 large cell medulloblastoma frameshift_variant 15.0% (6/40) 3 entries
ENSG00000167548 Fibroadenoma missense_variant 6.757% (5/74) 1 entry
ENSG00000167548 pancreatic ductal adenocarcinoma frameshift_variant 3.432% (59/1719) 3 entries
ENSG00000167548 basal cell carcinoma frameshift_variant 35.29% (24/68) 1 entry
ENSG00000167548 Dysplasia in Ulcerative Colitis missense_variant 37.5% (3/8) 1 entry
ENSG00000167548 Gallbladder Adenocarcinoma missense_variant 4.651% (8/172) 3 entries
ENSG00000167548 squamous cell lung carcinoma missense_variant 8.796% (84/955) 4 entries
ENSG00000167548 adrenal gland pheochromocytoma missense_variant 3.191% (9/282) 1 entry
ENSG00000167548 pharyngeal squamous cell carcinoma missense_variant 11.11% (9/81) 1 entry
ENSG00000167548 Breast Carcinoma by Gene Expression Profile stop_gained 7.955% (105/1320) 2 entries
ENSG00000167548 brain glioblastoma sequence_alteration 1.731% (21/1213) 2 entries
ENSG00000167548 esophageal adenocarcinoma missense_variant 3.285% (18/548) 2 entries
ENSG00000167548 medulloblastoma frameshift_variant 11.54% (3/26) 1 entry
ENSG00000167548 ovarian serous adenocarcinoma stop_gained 1.779% (15/843) 2 entries
ENSG00000167548 Ovarian Granulosa Cell Tumor frameshift_variant 13.33% (2/15) 1 entry
ENSG00000167548 skin carcinoma stop_gained 2.885% (3/104) 1 entry
ENSG00000167548 gastric tubular adenocarcinoma frameshift_variant 50.0% (1/2) 1 entry
ENSG00000167548 laryngeal squamous cell carcinoma missense_variant 17.07% (7/41) 1 entry
ENSG00000167548 angioimmunoblastic T-cell lymphoma conservative_inframe_deletion 4.348% (1/23) 1 entry
ENSG00000167548 follicular thyroid carcinoma frameshift_variant 1.429% (1/70) 1 entry
ENSG00000167548 chromophobe renal cell carcinoma frameshift_variant 2.454% (4/163) 1 entry
ENSG00000167548 salivary gland carcinoma stop_gained 6.061% (2/33) 1 entry
ENSG00000167548 acute myeloid leukemia sequence_alteration 1.063% (28/2633) 1 entry
ENSG00000167548 gastric tubular adenocarcinoma conservative_inframe_deletion 50.0% (1/2) 1 entry
ENSG00000167548 Vaginal Squamous Cell Carcinoma frameshift_variant 50.0% (1/2) 1 entry
ENSG00000167548 cervical carcinoma stop_gained 8.696% (2/23) 1 entry
ENSG00000167548 medullary thyroid gland carcinoma frameshift_variant 2.778% (1/36) 1 entry
ENSG00000167548 large cell lung carcinoma missense_variant 5.263% (1/19) 1 entry
ENSG00000167548 Chordoma missense_variant 7.143% (1/14) 1 entry
ENSG00000167548 Splenic Diffuse Large B-Cell Lymphoma stop_gained 75.0% (3/4) 1 entry
ENSG00000167548 endometrial carcinoma frameshift_variant 3.448% (1/29) 1 entry
ENSG00000167548 Ovarian Small Cell Carcinoma sequence_alteration 6.667% (1/15) 1 entry
ENSG00000167548 astrocytoma missense_variant 16.67% (1/6) 1 entry
ENSG00000167548 primary peritoneal carcinoma (disease) missense_variant 100.0% (1/1) 1 entry
ENSG00000167548 Gastrointestinal stromal tumor stop_gained 3.289% (5/152) 1 entry
ENSG00000167548 Duodenal Adenocarcinoma frameshift_variant 11.76% (2/17) 1 entry
ENSG00000167548 chromophobe renal cell carcinoma stop_gained 2.454% (4/163) 1 entry
ENSG00000167548 B-cell acute lymphoblastic leukemia amino_acid_insertion 4.487% (7/156) 1 entry
ENSG00000167548 myelodysplastic syndrome conservative_inframe_deletion 4.179% (29/694) 1 entry
ENSG00000167548 colonic neoplasm missense_variant 6.667% (1/15) 1 entry
ENSG00000167548 hairy cell leukemia missense_variant 4.167% (1/24) 1 entry
ENSG00000167548 Endometrial Undifferentiated Carcinoma missense_variant 33.33% (1/3) 1 entry
ENSG00000167548 salivary gland squamous cell carcinoma missense_variant 50.0% (1/2) 1 entry
ENSG00000167548 large cell medulloblastoma missense_variant 15.0% (6/40) 1 entry
ENSG00000167548 Cortisol-Producing Adrenal Cortex Adenoma frameshift_variant 0.8065% (1/124) 1 entry
ENSG00000167548 gastric adenocarcinoma conservative_inframe_deletion 7.592% (58/764) 1 entry
ENSG00000167548 dedifferentiated liposarcoma missense_variant 2.222% (1/45) 1 entry
ENSG00000167548 B-cell acute lymphoblastic leukemia stop_gained 4.487% (7/156) 1 entry
ENSG00000167548 clear cell renal carcinoma sequence_alteration 1.743% (32/1836) 1 entry
ENSG00000167548 gastric intestinal type adenocarcinoma conservative_inframe_deletion 12.04% (13/108) 1 entry
ENSG00000167548 medulloblastoma stop_gained 11.54% (3/26) 1 entry
ENSG00000167548 osteosarcoma frameshift_variant 0.6579% (1/152) 1 entry
ENSG00000167548 neuroendocrine carcinoma missense_variant 42.86% (3/7) 1 entry
ENSG00000167548 Malignant Ovarian Mixed Epithelial Tumor missense_variant 16.67% (1/6) 1 entry
ENSG00000167548 Thymic Undifferentiated Carcinoma frameshift_variant 14.29% (1/7) 1 entry
ENSG00000167548 T-cell acute lymphoblastic leukemia sequence_alteration 2.068% (14/677) 1 entry
ENSG00000167548 Ovarian Carcinosarcoma frameshift_variant 7.143% (1/14) 1 entry
ENSG00000167548 laryngeal squamous cell carcinoma frameshift_variant 17.07% (7/41) 1 entry
ENSG00000167548 colorectal adenoma missense_variant 11.11% (1/9) 1 entry
ENSG00000167548 Thymic Carcinoma missense_variant 27.27% (3/11) 1 entry
ENSG00000167548 Breast Diffuse Large B-Cell Lymphoma sequence_alteration 10.53% (2/19) 1 entry
ENSG00000167548 chronic myelomonocytic leukemia conservative_inframe_deletion 7.143% (11/154) 1 entry
ENSG00000167548 chronic myelomonocytic leukemia stop_gained 7.143% (11/154) 1 entry
ENSG00000167548 embryonal rhabdomyosarcoma frameshift_variant 3.488% (3/86) 1 entry
ENSG00000167548 Ampulla of Vater Carcinoma sequence_alteration 4.706% (4/85) 1 entry
ENSG00000167548 follicular thyroid carcinoma missense_variant 1.429% (1/70) 1 entry
ENSG00000167548 Thymic Carcinoma stop_gained 27.27% (3/11) 1 entry
ENSG00000167548 esophageal adenocarcinoma stop_gained 3.285% (18/548) 1 entry
ENSG00000167548 diffuse gastric adenocarcinoma sequence_alteration 3.571% (4/112) 1 entry
ENSG00000167548 carcinosarcoma sequence_alteration 100.0% (3/3) 1 entry
ENSG00000167548 Thymic Carcinoma frameshift_variant 27.27% (3/11) 1 entry
ENSG00000167548 pharyngeal squamous cell carcinoma frameshift_variant 11.11% (9/81) 1 entry
ENSG00000167548 solitary fibrous tumor stop_gained 3.448% (1/29) 1 entry
ENSG00000167548 small intestinal adenocarcinoma frameshift_variant 14.29% (3/21) 1 entry
ENSG00000167548 undifferentiated pleomorphic sarcoma frameshift_variant 4.839% (3/62) 1 entry
ENSG00000167548 pancreatic neuroendocrine tumor stop_gained 1.695% (4/236) 1 entry
ENSG00000167548 Appendix Adenocarcinoma sequence_alteration 3.896% (3/77) 1 entry
ENSG00000167548 medulloblastoma sequence_alteration 11.54% (3/26) 1 entry
ENSG00000167548 Thyroid Gland Undifferentiated (Anaplastic) Carcinoma frameshift_variant 3.788% (10/264) 1 entry
ENSG00000167548 gastric tubular adenocarcinoma missense_variant 50.0% (1/2) 1 entry
ENSG00000167548 Tonsillar Squamous Cell Carcinoma missense_variant 11.11% (1/9) 1 entry
ENSG00000167548 Vulvar Squamous Cell Carcinoma stop_gained 5.263% (1/19) 1 entry
ENSG00000167548 Ampulla of Vater Carcinoma frameshift_variant 4.706% (4/85) 1 entry
ENSG00000167548 Colorectal Neuroendocrine Tumor G1 missense_variant 20.0% (1/5) 1 entry
ENSG00000167548 well-differentiated liposarcoma stop_gained 5.556% (1/18) 1 entry
ENSG00000167548 salivary gland carcinoma frameshift_variant 6.061% (2/33) 1 entry
ENSG00000167548 Ampulla of Vater Carcinoma stop_gained 4.706% (4/85) 1 entry
ENSG00000167548 Cervical Adenosquamous Carcinoma frameshift_variant 20.0% (1/5) 1 entry
ENSG00000167548 chronic myelomonocytic leukemia amino_acid_insertion 7.143% (11/154) 1 entry
ENSG00000167548 Malignant Germ Cell Tumor missense_variant 100.0% (1/1) 1 entry
ENSG00000167548 endometrium adenocarcinoma frameshift_variant 6.667% (2/30) 1 entry
ENSG00000167548 Endometrial Clear Cell Adenocarcinoma missense_variant 7.407% (2/27) 1 entry
ENSG00000167548 testicular seminoma frameshift_variant 5.128% (4/78) 1 entry
ENSG00000167548 in situ carcinoma missense_variant 100.0% (1/1) 1 entry
ENSG00000167548 Duodenal Adenocarcinoma missense_variant 11.76% (2/17) 1 entry
ENSG00000167548 Invasive Breast Carcinoma frameshift_variant 6.522% (3/46) 1 entry
ENSG00000167548 Appendix Adenocarcinoma missense_variant 3.896% (3/77) 1 entry
ENSG00000167548 papillary thyroid carcinoma stop_gained 1.174% (6/511) 1 entry
ENSG00000167548 Cutaneous Follicular Lymphoma stop_gained 100.0% (2/2) 1 entry
ENSG00000167548 leiomyosarcoma missense_variant 1.98% (2/101) 1 entry
ENSG00000167548 embryonal rhabdomyosarcoma stop_gained 3.488% (3/86) 1 entry
ENSG00000167548 Minor Salivary Gland Adenocarcinoma conservative_inframe_deletion 50.0% (1/2) 1 entry
ENSG00000167548 angiosarcoma missense_variant 7.018% (4/57) 1 entry
ENSG00000167548 Adrenal Gland Neuroblastoma missense_variant 1.667% (1/60) 1 entry
ENSG00000167548 clear cell renal carcinoma conservative_inframe_deletion 1.743% (32/1836) 1 entry
ENSG00000167548 Sarcomatoid Mesothelioma missense_variant 100.0% (1/1) 1 entry
ENSG00000167548 Appendix Goblet Cell Carcinoid sequence_alteration 4.762% (1/21) 1 entry
ENSG00000167548 brain astrocytoma frameshift_variant 2.083% (1/48) 1 entry
ENSG00000167548 breast carcinoma sequence_alteration 2.75% (47/1709) 1 entry
ENSG00000167548 Gastric Neuroendocrine Tumor G1 missense_variant 11.11% (1/9) 1 entry
ENSG00000167548 nasal cavity and paranasal sinus carcinoma missense_variant 4.348% (1/23) 1 entry
ENSG00000167548 Merkel cell skin cancer sequence_alteration 15.79% (15/95) 1 entry
ENSG00000167548 Testicular Yolk Sac Tumor amino_acid_insertion 14.29% (1/7) 1 entry
ENSG00000167548 Anal Squamous Cell Carcinoma conservative_inframe_deletion 14.46% (12/83) 1 entry
ENSG00000167548 Cervical Clear Cell Adenocarcinoma amino_acid_insertion 100.0% (1/1) 1 entry
ENSG00000167548 female breast carcinoma stop_gained 4.11% (12/292) 1 entry
ENSG00000167548 Merkel cell skin cancer frameshift_variant 15.79% (15/95) 1 entry
ENSG00000167548 acute lymphoblastic leukemia amino_acid_insertion 5.607% (18/321) 1 entry
ENSG00000167548 B-cell acute lymphoblastic leukemia missense_variant 4.487% (7/156) 1 entry
ENSG00000167548 Benign Adrenal Gland Pheochromocytoma missense_variant 3.03% (1/33) 1 entry
ENSG00000167548 Mixed Lobular and Ductal Breast Carcinoma stop_gained 6.667% (5/75) 1 entry
ENSG00000167548 large cell medulloblastoma sequence_alteration 15.0% (6/40) 1 entry
ENSG00000167548 alveolar soft part sarcoma missense_variant 16.67% (1/6) 1 entry
ENSG00000167548 adrenocortical adenoma missense_variant 2.439% (1/41) 1 entry
ENSG00000167548 Gallbladder Adenocarcinoma stop_gained 4.651% (8/172) 1 entry
ENSG00000167548 Liver Cavernous Hemangioma missense_variant 16.67% (1/6) 1 entry
ENSG00000167548 nasopharyngeal squamous cell carcinoma sequence_alteration 8.696% (16/184) 1 entry
ENSG00000167548 ovarian adenocarcinoma missense_variant 10.0% (1/10) 1 entry
ENSG00000167548 leiomyosarcoma frameshift_variant 1.98% (2/101) 1 entry
ENSG00000167548 undifferentiated pleomorphic sarcoma stop_gained 4.839% (3/62) 1 entry
ENSG00000167548 rectal adenocarcinoma stop_gained 4.762% (26/546) 1 entry
ENSG00000167548 Pancreatic Acinar Cell Carcinoma missense_variant 8.824% (3/34) 1 entry
ENSG00000167548 Mixed Lobular and Ductal Breast Carcinoma frameshift_variant 6.667% (5/75) 1 entry
ENSG00000167548 ovarian serous adenocarcinoma frameshift_variant 1.779% (15/843) 1 entry
ENSG00000167548 nasal cavity and paranasal sinus carcinoma stop_gained 4.348% (1/23) 1 entry
ENSG00000167548 kidney Wilms tumor missense_variant 0.3115% (1/321) 1 entry
ENSG00000167548 B-cell acute lymphoblastic leukemia sequence_alteration 4.487% (7/156) 1 entry
ENSG00000167548 primary peritoneal carcinoma (disease) frameshift_variant 100.0% (1/1) 1 entry
ENSG00000167548 dedifferentiated chondrosarcoma missense_variant 5.882% (1/17) 1 entry
ENSG00000167548 Skin Basosquamous Cell Carcinoma stop_gained 100.0% (1/1) 1 entry
ENSG00000167548 carcinoid tumor frameshift_variant 16.67% (1/6) 1 entry
ENSG00000167548 ovarian serous adenocarcinoma conservative_inframe_deletion 1.779% (15/843) 1 entry
ENSG00000167548 diffuse gastric adenocarcinoma missense_variant 3.571% (4/112) 1 entry
ENSG00000167548 Thymic Squamous Cell Carcinoma missense_variant 3.704% (1/27) 1 entry
ENSG00000167548 Pleural Epithelioid Mesothelioma sequence_alteration 2.439% (5/205) 1 entry
ENSG00000167548 meningioma (disease) missense_variant 1.37% (1/73) 1 entry
ENSG00000167548 Endometrial Clear Cell Adenocarcinoma stop_gained 7.407% (2/27) 1 entry
ENSG00000167548 non-small cell lung carcinoma frameshift_variant 5.155% (5/97) 1 entry
ENSG00000167548 multiple myeloma missense_variant 2.222% (1/45) 1 entry
ENSG00000167548 Merkel cell skin cancer amino_acid_insertion 15.79% (15/95) 1 entry
ENSG00000167548 rectal adenocarcinoma conservative_inframe_deletion 4.762% (26/546) 1 entry
ENSG00000167548 acute myeloid leukemia amino_acid_insertion 1.063% (28/2633) 1 entry
ENSG00000167548 esophageal adenocarcinoma conservative_inframe_deletion 3.285% (18/548) 1 entry
ENSG00000167548 alveolar rhabdomyosarcoma stop_gained 1.538% (1/65) 1 entry
ENSG00000167548 skin melanoma frameshift_variant 8.755% (102/1165) 1 entry
ENSG00000167548 Parotid Gland Adenoid Cystic Carcinoma frameshift_variant 7.692% (1/13) 1 entry
ENSG00000167548 Thymic Undifferentiated Carcinoma missense_variant 14.29% (1/7) 1 entry
ENSG00000167548 renal cell carcinoma missense_variant 1.449% (1/69) 1 entry
ENSG00000167548 Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor stop_gained 3.03% (1/33) 1 entry
ENSG00000167548 adrenal cortex carcinoma stop_gained 1.587% (3/189) 1 entry
ENSG00000167548 Myelodysplastic/Myeloproliferative Neoplasm missense_variant 7.143% (1/14) 1 entry
ENSG00000167548 Appendix Adenocarcinoma frameshift_variant 3.896% (3/77) 1 entry
ENSG00000167548 endometrium adenocarcinoma stop_gained 6.667% (2/30) 1 entry
ENSG00000167548 pseudomyxoma peritonei missense_variant 10.0% (1/10) 1 entry
ENSG00000167548 Anal Squamous Cell Carcinoma sequence_alteration 14.46% (12/83) 1 entry
ENSG00000167548 Breast Carcinoma by Gene Expression Profile sequence_alteration 7.955% (105/1320) 1 entry
ENSG00000167548 Gastrointestinal stromal tumor sequence_alteration 3.289% (5/152) 1 entry
Ensembl ID Gene symbol Cancer P-value Which worse show
ENSG00000167548 MESO 0.0081 high
ENSG00000167548 STAD 0.031 low
ENSG00000167548 UVM 0.0057 low
ENSG00000167548 THCA 0.036 high
ENSG00000167548 LGG 0.029 high
ENSG00000167548 LUSC 0.025 high
ENSG00000167548 HNSC 0.0063 low
ENSG00000167548 LUAD 0.026 low
ENSG00000167548 PCPG 0.028 low
ENSG00000167548 THYM 0.029 low
ENSG00000167548 BRCA 0.0053 low
ENSG00000167548 COAD 0.05 high
ENSG00000167548 OV 0.05 high
ENSG00000167548 KIRC 0.014 low
ENSG00000167548 PRAD 0.048 low
ENSG00000167548 LAML 0.024 low
ENSG00000167548 GBM 0.034 low
ENSG00000167548 SKCM 0.034 high
Ensembl ID Gene symbol Cancer CNV type -log10(q-value) G-score average amplitude frequency
ENSG00000167548 LGG Del 0.622630 0.037777 0.431822 0.132554
ENSG00000167548 GBM Del 0.690656 0.051599 0.464618 0.128250
ENSG00000167548 PAAD Del 0.945408 0.050602 0.380543 0.179348